基于"化合物-目标-通路"网络,探索阿库图米丁对心肌缺血的保护作用和潜在机制
Jia Shao1,2, Rongrong Zheng3, Meng Liu3
1Department of Pharmacy, Tianjin First Central Hospital, Tianjin, China.
Combinatorial chemistry & high throughput screening
|September 15, 2025
概括
来自Menispermi Rhizoma的阿库图米丁通过抑制氧化应激和亡,有效治疗心肌缺血症 (MI). 这项研究探讨了它对心脏病发作治疗的多目标机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
- 传统中国医药 传统中国医药
背景情况:
- 阴茎瘤是一种传统的中医药,具有已知的抗心肌缺血症 (MI) 作用.
- 阿库图米丁是Menispermi Rhizoma的一个关键类化合物,但它对MI的治疗机制在很大程度上仍未被探索.
- 这项研究调查了阿库图米丁在治疗心脏病发作中的有效性和潜在机制.
研究的目的:
- 阐明阿库图米丁对心肌缺血 (MI) 的保护作用.
- 为了确定分子点和信号通路,参与了阿库图米丁对心脏病发作的作用.
- 为了验证阿库图米丁在心脏病发作治疗中的治疗潜力.
主要方法:
- 在H9c2心肌细胞中建立了氧气-葡萄糖剥夺 (OGD) 模型,以模拟MI.
- 采用网络药理学来预测MI中阿库图米丁的潜在标和途径.
- 利用分子对接来验证关键目标和蛋白质与蛋白质相互作用.
主要成果:
- 阿库图米丁通过提高抗氧化剂水平 (SOD,GSH) 和减少细胞损伤标志物 (LDH,CK,MDA) 和亡,显示出心脏保护作用.
- 网络药理学确定PI3K/AKT,HIF-1和Ras信号通路对于阿库图米丁的MI改善作用至关重要.
- 分子对接证实了MAPK1,ESR1,EGFR,IGF1和CASP3作为心脏病治疗中阿库图米丁的核心标.
结论:
- 阿库图米丁有效抑制氧化应激和心肌细胞亡,为心脏病发作提供了显著的治疗潜力.
- 在MI中,阿库图米丁的药理效应涉及多个标和信号通路,突出其复杂的作用机制.
相关概念视频
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:14Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
01:21Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
01:30Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828